Telehealth & Digital Health

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

A new alliance between Tend Health and SafeHavenMD offers a confidential lifeline to doctors battling burnout, integrating peer support with clinical care.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Heart disease is the leading cause of premature death for Canadian women, yet it remains under-diagnosed and under-treated. A national movement is fighting back.

A 15-year pharma alliance expands to Austria, bringing advanced relief to cancer patients suffering from chemotherapy's debilitating side effects.

Zoya Technologies unveils an autonomous AI clinic that operates without the cloud, promising to revolutionize healthcare in underserved regions worldwide.

A national scholarship founded by a top neurosurgeon invests in students poised to solve healthcare’s biggest challenges, addressing critical workforce shortages.

Airrosti launches REACH, a new platform combining its proven myofascial release model with digital tools to tackle the $350B MSK problem.

After winning a major award, OnMed's tech-enabled CareStation promises to revolutionize access to care. But can this hybrid model solve a national crisis?

A new 7,500-participant study will test a cfDNA-based screen to identify high-risk pregnancies months before symptoms appear, a potential paradigm shift.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

A new study reveals why Sickle Cell Disease patients suffer from frequent crises and rely on pain pills, even with awareness of multi-million dollar cures.

A new initiative unites top scientists to study 'SuperAgers' and resilient brains, aiming to unlock the secrets of healthy aging and prevent Alzheimer's.

A new report reveals a looming crisis: rising healthcare costs will consume more than 100% of Social Security benefits for future generations of retirees.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

VectorY Therapeutics adds seasoned biotech architect Kevin Pojasek to its board, signaling a strategic push to accelerate its novel therapies for ALS and Alzheimer's.

A new report reveals how GLP-1 drugs are accelerating a major healthcare shift in the Gulf, turning metabolic health into a core economic and policy issue.